Investments (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended		12 Months Ended
	May. 30, 2006	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2012
Payment for business combination		$ 50,000
Global Cancer [Member]
Payment for business combination		$ 50,000
Business combination contingent payment terms		In the event the Company and Global execute definitive merger documents contemplated by the Global LOI on or before the Termination Date, Global will issue to the Company that number of shares of Global’s common stock equal to 10% of the then outstanding shares of Global’s common stock, on a fully-diluted basis as payment of the Global Advance.
FluoroPharma [Member]
Gain on warrants issued			$ 20,660	$ 115,752
Reassignment of warrants			109,917
Warrant price			$ 1.00
GenomicsUSA [Member]
Purchase of stock	144,024
Payment for stock	$ 200,000
Equity ownership	5.00%	2.00%